[Use of esophageal investigation in the mid-term outcome after radiofrequency ablation of intranodal reentrant tachycardia]

Arch Mal Coeur Vaiss. 1996 Nov;89(11):1375-9.
[Article in French]

Abstract

The aim of this prospective study was to assess the medium term results of radio-frequency ablation of intranodal tachycardias by transoesophageal stimulation and recordings. Transoesophageal stimulation was performed on average 9 months after ablation. The anterograde Wenckebach point, the presence of dual nodal conduction and inducibility of nodal tachycardias were determined under basal conditions and after isoproterenol. The follow-up period after ablation was 16.1 +/- 10.2 months. At the time of the oesophageal investigation 25 patients were asymptomatic and 5 had a recurrence of palpitations. The investigation was carried out without complications in all patients and lasted 34.8 +/- 14 minutes. The anterograde Wenckebach point was 340 +/- 78.2 ms and was unchanged compared with the value recorded by endocavitary left atrial stimulation before ablation (332 +/- 63.2 ms). Dual nodal conduction was observed in 19 patients. Nodal tachycardia was inducible in only 2 of the 5 patients with palpitations. Of the asymptomatic patients, 3 had inducible nodal tachycardias after isoproterenol. The authors conclude that oesophageal electrophysiological studies are a simple means of assessing the medium-term results of radiofrequency ablation of intranodal tachycardias. In those patients with a recurrence of symptoms but without documented arrhythmias, failure of radiofrequency ablation may be identified. In addition, the possibility of inducing nodal tachycardias in asymptomatic patients may be detected.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Cardiac Pacing, Artificial / methods*
  • Catheter Ablation*
  • Esophagus
  • Female
  • Follow-Up Studies
  • Heart Conduction System / physiopathology
  • Heart Conduction System / surgery*
  • Humans
  • Isoproterenol
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Prospective Studies
  • Recurrence
  • Sympathomimetics
  • Tachycardia, Sinoatrial Nodal Reentry / physiopathology
  • Tachycardia, Sinoatrial Nodal Reentry / surgery*
  • Treatment Outcome

Substances

  • Sympathomimetics
  • Isoproterenol